Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (...

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)  PR Newswire

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations ...

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations  Regulatory Affairs Professionals Society | RAPS

Swissmedic approves IFINWIL for children with high-risk neuroblastoma - Pharmaceutical Technology

Swissmedic approves IFINWIL for children with high-risk neuroblastoma  Pharmaceutical Technology

Swissmedic approves first malaria treatment for infants - drugdiscoverytrends.com

Swissmedic approves first malaria treatment for infants  drugdiscoverytrends.com

Swissmedic plans job cuts amid mounting financial pressures - SWI swissinfo.ch

Swissmedic plans job cuts amid mounting financial pressures  SWI swissinfo.ch

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY - Busin...

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY  Business Wire

Swissmedic & Sweden's MPA Sign MoU to Boost Cooperation - NAVLIN DAILY

Swissmedic & Sweden's MPA Sign MoU to Boost Cooperation  NAVLIN DAILY

Horizon Scanning - Visible - Swissmedic

Horizon Scanning - Visible  Swissmedic

Euro Roundup: Swissmedic mandates nitrosamine risk assessments in some applications - Regulatory ...

Euro Roundup: Swissmedic mandates nitrosamine risk assessments in some applications  Regulatory Affairs Professionals Society | RAPS

Swissmedic approves Novartis’ malaria medicine for babies - Pharmaceutical Technology

Swissmedic approves Novartis’ malaria medicine for babies  Pharmaceutical Technology

Agency for Therapeutic Products: Swissmedic to cut around 45 full-time positions within two years...

Agency for Therapeutic Products: Swissmedic to cut around 45 full-time positions within two years | blue News  blue News

U.S.–Swiss Mutual Recognition Agreement on Good Manufacturing Practices - Sidley Austin

U.S.–Swiss Mutual Recognition Agreement on Good Manufacturing Practices  Sidley Austin

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein...

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)  the-scientist.com

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeu...

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics  Greater Geneva Bern area

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory...

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective  ASCO Publications

Counterfeit Ozempic diabetes medication in circulation - Swissmedic

Counterfeit Ozempic diabetes medication in circulation  Swissmedic

Swissmedic updates guidances on API, fast-track pathway, and more - Regulatory Affairs Profession...

Swissmedic updates guidances on API, fast-track pathway, and more  Regulatory Affairs Professionals Society | RAPS

Swissmedic updates adverse event reporting requirements for 2024 - Regulatory Affairs Professiona...

Swissmedic updates adverse event reporting requirements for 2024  Regulatory Affairs Professionals Society | RAPS

Swissmedic updates guidance on temporary medicine authorization to harmonize deadlines - Regulato...

Swissmedic updates guidance on temporary medicine authorization to harmonize deadlines  Regulatory Affairs Professionals Society | RAPS

Euro Roundup: Swissmedic clarifies how foreign manufacturers can demonstrate GMP compliance - Reg...

Euro Roundup: Swissmedic clarifies how foreign manufacturers can demonstrate GMP compliance  Regulatory Affairs Professionals Society | RAPS

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution -...

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution  Swissmedic

Swissmedic moves more slowly in reviewing medicines - The Pharma Letter

Swissmedic moves more slowly in reviewing medicines  The Pharma Letter

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility ...

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility in Solothurn, Switzerland  Biogen

Study: FDA more likely to approve drugs for broader populations than EMA, Swissmedic - Regulatory...

Study: FDA more likely to approve drugs for broader populations than EMA, Swissmedic  Regulatory Affairs Professionals Society | RAPS

Novartis receives approval for first malaria medicine for newborn babies and young infants - Nova...

Novartis receives approval for first malaria medicine for newborn babies and young infants  Novartis

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine - Reuters

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine  Reuters

Euro Roundup: Switzerland updates legislation to improve clinical trial framework - Regulatory Af...

Euro Roundup: Switzerland updates legislation to improve clinical trial framework  Regulatory Affairs Professionals Society | RAPS

Kamada’s Glassia receives marketing approval from Swissmedic - Pharmaceutical Technology

Kamada’s Glassia receives marketing approval from Swissmedic  Pharmaceutical Technology

Switzerland and US sign GMP Mutual Recognition Agreement - European Pharmaceutical Review

Switzerland and US sign GMP Mutual Recognition Agreement  European Pharmaceutical Review

Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD - Yahoo Finance

Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD  Yahoo Finance

Homepage - Visible - Swissmedic

Homepage - Visible  Swissmedic

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic - Reuters

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic  Reuters

Regulatory & Beyond 2024 - Swissmedic

Regulatory & Beyond 2024  Swissmedic

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal p...

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal products  Swissmedic

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020 - Swissmedic

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020  Swissmedic

European Regulatory Roundup: Swissmedic Proposes Overhaul of Drug Ordinances (29 June 2017) - Reg...

European Regulatory Roundup: Swissmedic Proposes Overhaul of Drug Ordinances (29 June 2017)  Regulatory Affairs Professionals Society | RAPS

Swiss medicines regulator responds to Trump’s paracetamol claim - SWI swissinfo.ch

Swiss medicines regulator responds to Trump’s paracetamol claim  SWI swissinfo.ch

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulato...

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulatory bodies?  Public Eye

IceCure (NASDAQ: ICCM) receives Swissmedic approval for ProSense in breast and lung cancer - Stoc...

IceCure (NASDAQ: ICCM) receives Swissmedic approval for ProSense in breast and lung cancer  Stock Titan

Swiss delay AstraZeneca COVID vaccine approval, order more shots from others - Reuters

Swiss delay AstraZeneca COVID vaccine approval, order more shots from others  Reuters

Consolidating veterinary medicinal product expertise - Swissmedic

Consolidating veterinary medicinal product expertise  Swissmedic

Operation PANGEA XV: International campaign against falsified and illegally imported medicinal pr...

Operation PANGEA XV: International campaign against falsified and illegally imported medicinal products  Swissmedic

Cannabis for medical purposes - Visible - Swissmedic

Cannabis for medical purposes - Visible  Swissmedic

Landmark listing of first three countries as WHO-Listed regulatory Authorities - World Health Org...

Landmark listing of first three countries as WHO-Listed regulatory Authorities  World Health Organization (WHO)

Swissmedic participates in FDA Project Orbis - Swissmedic

Swissmedic participates in FDA Project Orbis  Swissmedic

"Gender medicine is not a lifestyle issue – it's clinically relevant" - Swissmedic

"Gender medicine is not a lifestyle issue – it's clinically relevant"  Swissmedic

Legal Affairs - Visible - Swissmedic

Legal Affairs - Visible  Swissmedic

CHUV introduces Switzerland's first gut-balancing medication - Greater Geneva Bern area

CHUV introduces Switzerland's first gut-balancing medication  Greater Geneva Bern area

Committed to the next generation - Swissmedic

Committed to the next generation  Swissmedic

Swissmedic approves Novartis' new heart failure medicine Entresto(TM) - Novartis

Swissmedic approves Novartis' new heart failure medicine Entresto(TM)  Novartis

VMD and Swissmedic agree collaboration on veterinary medicinal products - GOV.UK

VMD and Swissmedic agree collaboration on veterinary medicinal products  GOV.UK

What does the name Swissmedic mean to you? - Swissmedic

What does the name Swissmedic mean to you?  Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update - Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update  Swissmedic

Swissmedic vaccine videos – part 4 - Swissmedic

Swissmedic vaccine videos – part 4  Swissmedic

Meet René: The IDF’s First Ever Swiss-Bedouin Medic - idf.il

Meet René: The IDF’s First Ever Swiss-Bedouin Medic  idf.il

Future developments - Visible - Swissmedic

Future developments - Visible  Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic - Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic  Swissmedic

Swiss regulator and media clash over weight-loss drugs - SWI swissinfo.ch

Swiss regulator and media clash over weight-loss drugs  SWI swissinfo.ch

Illegally imported medicinal products: underestimated risks! - Swissmedic

Illegally imported medicinal products: underestimated risks!  Swissmedic

Operation PANGEA XIV: campaign against counterfeit and illegally imported medicinal products - Sw...

Operation PANGEA XIV: campaign against counterfeit and illegally imported medicinal products  Swissmedic

The handbook of medicinal product quality - Swissmedic

The handbook of medicinal product quality  Swissmedic

We supply real-world examples, results and data - Swissmedic

We supply real-world examples, results and data  Swissmedic

Improving international collaboration – MHRA and Swissmedic sign MoU - GOV.UK

Improving international collaboration – MHRA and Swissmedic sign MoU  GOV.UK

The Shady Business Of Experimental Stem Cell Treatments - Worldcrunch

The Shady Business Of Experimental Stem Cell Treatments  Worldcrunch

Market surveillance - Visible - Swissmedic

Market surveillance - Visible  Swissmedic

Swissmedic takes action over Fettweg articles: Media censorship or justified warning? - Pomona - ...

Swissmedic takes action over Fettweg articles: Media censorship or justified warning?  Pomona - Das Wallis im Hosensack

Swissmedic approves Roche’s Ronapreve to treat COVID-19 patients - The Fiji Times

Swissmedic approves Roche’s Ronapreve to treat COVID-19 patients  The Fiji Times

Personalisierter Hirnstimulator bei Swissmedic registriert - Medinside

Personalisierter Hirnstimulator bei Swissmedic registriert  Medinside

Swissmedic baut innert zweier Jahre rund 45 Vollzeitstellen ab - Südostschweiz

Swissmedic baut innert zweier Jahre rund 45 Vollzeitstellen ab  Südostschweiz

Switzerland Clears First Malaria Medicine for Small Babies - Adda247

Switzerland Clears First Malaria Medicine for Small Babies  Adda247